Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fragments of the African cassava mosaic virus (ACMV) genome, cloned upstream of the
beta-glucuronidase
(GUS) reporter gene in an expression cassette, were analysed for their ability to direct complementary-sense gene expression in tobacco protoplasts by measuring GUS activity. Five arbitrary domains (A-E) have been designated that contribute to the expression of AC1 (replication-associated protein) and
AC4
. Consistent with earlier reports, AC1 gene expression was negatively regulated (80% reduction in activity) by its own protein product, and suppression was mimicked by truncated versions of AC1 comprising the N-terminal 57 amino acids. AC1 also suppressed
AC4
gene expression to a similar extent. Nucleotide sequences responsible for suppression were mapped to domain A, a 92 bp fragment located immediately upstream of the AC1 initiation codon encompassing the consensus TATA box and transcription start point. Complementary-sense gene expression also decreased by 30-40% in the presence of AV1 (coat protein) although other DNA A-encoded proteins (AV2, AC2, AC3 and
AC4
) had no effect. The results are discussed in the light of recent advances concerning the initiation of viral DNA replication and the control of gene expression.
...
PMID:Regulation of African cassava mosaic virus complementary-sense gene expression by N-terminal sequences of the replication-associated protein AC1. 759 45